Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Batch consistency study of live attenuated varicella vaccine in healthy children aged 1 to 12 years
CTR20223180Phase 3Active
- Sponsor
- Beijing Institute of Biological Products
- Start
- Apr 2023
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, Live Biotherapeutic Products → Microbiome Therapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of varicella virus vaccine live in chickenpox, sponsored by Beijing Institute of Biological Products. Started Apr 2023; status: active.
02
Drugs
varicella virus vaccine live
03
Conditions
chickenpox
Beyond the preview
Go deeper on CTR20223180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223180.